Dinesh Chellappan to Coronavirus Infections
This is a "connection" page, showing publications Dinesh Chellappan has written about Coronavirus Infections.
Connection Strength
0.075
-
Middle East Respiratory Syndrome (MERS) Virus-Pathophysiological Axis and the Current Treatment Strategies. AAPS PharmSciTech. 2021 Jun 08; 22(5):173.
Score: 0.030
-
Gender and Age Differences Reveal Risk Patterns in COVID-19 Outbreak. Altern Ther Health Med. 2020 Aug; 26(S2):54-55.
Score: 0.007
-
Are Medicinal Plants an Alternative Strategy to Combat COVID-19? Altern Ther Health Med. 2020 Aug; 26(S2):92-93.
Score: 0.007
-
Vesicular drug delivery systems as theranostics in COVID-19. Future Med Chem. 2020 09; 12(18):1607-1609.
Score: 0.007
-
RAAS blockers in hypertension posing a higher risk toward the COVID-19. Dermatol Ther. 2020 Jul; 33(4):e13501.
Score: 0.007
-
COVID-19 transmission through host cell directed network of GPCR. Drug Dev Res. 2020 09; 81(6):647-649.
Score: 0.007
-
COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development. Pharm Nanotechnol. 2020; 8(4):323-353.
Score: 0.007
-
Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective. Life Sci. 2021 Sep 01; 280:119744.
Score: 0.002
-
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J Mol Neurosci. 2021 Nov; 71(11):2192-2209.
Score: 0.002